Novo Nordisk A/S
Novo Nordisk hikes outlook on soaring demand for Wegovy, Ozempic
An Ozempic (semaglutide) injection pen is seen on a kitchen table in Riga, Latvia on 06 August, 2023. Jaap Arriens | Nurphoto | Getty Images Novo Nordisk on Friday raised its outlook for its full-year sales and operating profit due to soaring demand for its blockbuster weight loss drug Wegovy and diabetes treatment Ozempic. The […]
Read More
LVMH shares tumble to 2023 small as growth slows, pulling luxury sector down
A LVMH Moet Hennessy Louis Vuitton SE store in Shanghai, China on Wednesday, June 14, 2023. Bloomberg | Bloomberg | Getty Illustrations or photos Shares of LVMH dropped to their least expensive amount of the yr on Wednesday morning, just after the corporation reported a slowdown in income progress that was beneath anticipations. The stock […]
Read More
How Ozempic and Wegovy turned Novo Nordisk into a $400 billion company
Danish drugmaker Novo Nordisk has entered a new chapter in its 100-year history — thanks to its newfound success with two products: Ozempic and Wegovy. The drugs are once-weekly injectables of a medication called semaglutide, prescribed for Type 2 diabetes and weight loss. Their skyrocketing popularity has boosted Novo Nordisk to new heights. Novo Nordisk’s […]
Read More
Weight loss drugs may be linked to stomach paralysis, other rare but severe issues, study says
Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity. Michael Siluk | UCG | Getty Images Blockbuster weight loss and diabetes drugs like Wegovy and Ozempic may be associated with an increased risk of three rare, […]
Read More
Drugmakers opt in to Medicare drug price negotiations – here’s what happens next
A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo, Utah, January 9, 2020. George Frey | Reuters All drugmakers of the first 10 medicines selected for Medicare drug price negotiations have agreed to participate in the talks, even after many of them sued to halt the […]
Read More
Big Food vs. Big Pharma: Companies bet on snacking just as weight loss drugs boom
The snack aisle is seen during a tour of a new Amazon Go store in the Capitol Hill neighborhood of Seattle, Washington, U.S., on Monday, Feb. 24, 2020. Chona Kasinger | Bloomberg | Getty Images For more than a century, frosted cornflakes have been the backbone of Kellogg’s business. That changes Monday, when the company […]
Read More
Shares of biotech startup Structure Therapeutics surge more than 30% on promising obesity pill data
Aykut Karahan | Istock | Getty Images Shares of Structure Therapeutics rose more than 30% on Friday after the biotech startup’s experimental obesity pill succeeded in a small early-stage trial. The once-daily drug helped overweight or obese participants reduce up to 10 pounds of weight on average after four weeks of treatment, according to a […]
Read More
Ad spending for obesity, diabetes drugs is soaring this year, as drugmakers shell out nearly $500 million
A view of a plastic model of a stomach during an interview with Doctor Thomas Horbach, specialist in surgery, visceral surgery and nutritional medicine on Novo Nordisk, which will start selling its hugely popular obesity drug Wegovy in Germany later this month, in Munich, Germany, July 17, 2023. Christine Uyanik | Reuters Drugmakers spent nearly […]
Read More
Will weight loss drugs lead to less food consumption? Here’s what Walmart is saying
More than 40% of adults in the U.S. are obese. That’s a big number, which makes the group a force to be reckoned with if their habits start to change suddenly. That’s why we’ve seen so many Wall Street analysts exploring the potential fallout from new weight loss medications like Novo Nordisk’s Wegovy and Ozempic […]
Read More
Ozempic, Wegovy drug prescriptions hit 9 million, surge 300% in under three years
A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023. George Frey | Reuters U.S. health care providers wrote more than nine million prescriptions for Ozempic, Wegovy and similar diabetes and obesity drugs during […]
Read More